SM
JUNO

Sabby Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Sabby Management’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-11,333
Closed -$604K – 428
2015
Q2 		$604K Buy
+11,333
New +$602K 0.02% 251

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Sabby Management's JUNO Position: Q3 2015 in Review

Sabby Management sold out of Juno Therapeutics, Inc. (JUNO) in Q3 2015, closing a stake of 11,333 shares — an estimated $604K sold.

Sabby Management first reported a position in JUNO in Q2 2015 and held it in 1 quarter. The position peaked at $604K in Q2 2015. 132 funds tracked by Wall St. Rank hold JUNO as of Q3 2015.

  • Sabby Management reported no remaining Juno Therapeutics, Inc. position as of Q3 2015 after selling out during the quarter.
  • Sabby Management sold 11,333 Juno Therapeutics, Inc. shares in Q3 2015, an estimated $604K.
  • Sabby Management first reported a position in Juno Therapeutics, Inc. in Q2 2015 and held it in 1 quarter.
  • Sabby Management's Juno Therapeutics, Inc. position peaked at $604K in Q2 2015.
  • 132 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q3 2015.

Based on Sabby Management's 13F filing for Q3 2015, filed 16 Nov 2015.